Arcutis Biotherapeutics, Inc.: Form 8-K, filed Jun 17, 2025
Filed with the SEC on Jun 17, 2025 and accepted by EDGAR at Jun 17, 2025, 16:52 ET.
Items reported
- Item 5.07 Shareholder vote results
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001787306-25-000096. Last ingested by Listed: Oct 28, 2026, 09:04 ET. Listed shows no prices and gives no investment advice.